California-based startup Apreo Health has raised $130m to further the development of its implant for treating severe emphysema.

A key trend in the medical device market is smaller and smarter, which requires advanced materials and is the focus of the ...

The US Federal Trade Commission (FTC) is suing Edwards Lifesciences to stop it from acquiring JenaValve, citing anticompetitive concerns.

Freenome has entered an exclusive licence agreement with Exact Sciences, granting the latter the rights to commercialise Freenome's blood-based CRC screening test in the US.

Medical Device Network sat down with Dexcom's outgoing CEO Kevin Sayer to learn more about how the company will maintain its market position and drive innovation in the CGM space in the future.